Genomics

Dataset Information

0

Genomic analyses of gynecologic carcinosarcomas reveal frequent mutations in chromatin remodeling genes


ABSTRACT: Malignant Mixed Müllerian Tumors, also known as carcinosarcomas, are rare tumors of gynecological origin. Here we perform whole exome analyses of 22 tumors using massively parallel sequencing to determine the mutational landscape of this tumor type. On average, we identify 43 mutations per tumor, excluding four cases with a mutator phenotype that harbored inactivating mutations in mismatch repair genes. In addition to mutations in TP53 and KRAS, we identify genetic alterations in chromatin remodeling genes, ARID1A and ARID1B, in histone methyltransferase MLL3, in histone deacetylase modifier SPOP, and in chromatin assembly factor BAZ1A, in nearly two thirds of cases. Alterations in genes with potential clinical utility are observed in more than three quarters of the cases and included members of the PI 3-kinase and homologous DNA repair pathways. These findings highlight the importance of the dysregulation of chromatin remodeling in carcinosarcoma tumorigenesis and suggest new avenues for personalized therapy.

PROVIDER: EGAS00001000941 | EGA |

REPOSITORIES: EGA

altmetric image

Publications


Malignant mixed Müllerian tumours, also known as carcinosarcomas, are rare tumours of gynaecological origin. Here we perform whole-exome analyses of 22 tumours using massively parallel sequencing to determine the mutational landscape of this tumour type. On average, we identify 43 mutations per tumour, excluding four cases with a mutator phenotype that harboured inactivating mutations in mismatch repair genes. In addition to mutations in TP53 and KRAS, we identify genetic alterations in chromati  ...[more]

Similar Datasets

2016-07-21 | E-MTAB-4641 | biostudies-arrayexpress
2024-01-10 | PXD041132 | Pride
| PRJNA150243 | ENA
| EGAS00001000369 | EGA
| EGAD00001000282 | EGA
2022-04-05 | GSE152292 | GEO
2024-01-26 | PXD034337 | Pride
2024-01-26 | PXD040928 | Pride
| 2322588 | ecrin-mdr-crc
2024-09-09 | PXD048170 | Pride